1 1 Functions of Gtf2i and Gtf2ird1 in the Developing Brain

Total Page:16

File Type:pdf, Size:1020Kb

1 1 Functions of Gtf2i and Gtf2ird1 in the Developing Brain bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 2 Functions of Gtf2i and Gtf2ird1 in the developing brain: transcription, DNA-binding, 3 and long term behavioral consequences. 4 5 6 Authors: 7 Nathan D. Kopp1,2, Kayla R. Nygaard1,2, Katherine B. McCullough1,2, Susan E. Maloney2,3, 8 Harrison W. Gabel4, Joseph D. Dougherty1,2,3,* 9 10 11 Affiliations: 12 13 1Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA 14 2Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA 15 3Intellectual and Developmental Disabilities Research Center, Washington University School 16 of Medicine, St. Louis, MO, USA 17 4Department of Neuroscience, Washington University School of Medicine, St Louis MO, USA 18 19 Contact Information: 20 Dr. Joseph Dougherty 21 Department of Genetics 22 Campus Box 8232 23 4566 Scott Ave. 24 St. Louis, MO. 63110-1093 25 P: 314-286-0752 26 F: 314-362-7855 27 E: [email protected] 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 1 bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 2 Abstract 3 4 Gtf2ird1 and Gtf2i may mediate aspects of the cognitive and behavioral phenotypes 5 of Williams Syndrome (WS) – a microdeletion syndrome encompassing these 6 transcription factors (TFs). Knockout mouse models of each TF show behavioral 7 phenotypes. Here we identify their genomic binding sites in the developing brain, 8 and test for additive effects of their mutation on transcription and behavior. Both 9 TFs target constrained chromatin modifier and synaptic protein genes, including a 10 significant number of ASD genes. They bind promoters, strongly overlap CTCF 11 binding and TAD boundaries, and moderately overlap each other, suggesting 12 epistatic effects. We used single and double mutants to test whether mutating both 13 TFs will modify transcriptional and behavioral phenotypes of single Gtf2ird1 14 mutants. Despite little difference in DNA-binding and transcriptome-wide 15 expression, Gtf2ird1 mutation caused balance, marble burying, and conditioned fear 16 phenotypes. However, mutating Gtf2i in addition to Gtf2ird1 did not further modify 17 transcriptomic or most behavioral phenotypes, suggesting Gtf2ird1 mutation alone 18 is sufficient. 19 20 21 22 23 24 25 2 bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 2 Introduction 3 4 The Williams syndrome critical region (WSCR) contains 28 genes that are 5 typically deleted in Williams syndrome (WS) (OMIM#194050). The genes in this 6 region are of interest for their potential to contribute to the unique physical, 7 cognitive, and behavioral phenotypes of WS, which include craniofacial 8 dysmorphology, mild to severe intellectual disability, poor visuospatial cognition, 9 balance and coordination problems, and a characteristic hypersocial personality (1– 10 3). Single gene knockout mouse models exist for many of the genes in the region, 11 with differing degrees of face validity for WS phenotypes (4–9). Two genes have 12 been highlighted in the human and mouse literature as playing a large role in the 13 social and cognitive tasks: Gtf2i and Gtf2ird1. Mouse models of each gene have 14 shown social phenotypes as well as balance and anxiety phenotypes (4,8–12). Since 15 evidence shows that each gene affects similar behaviors, we set out to test the 16 hypothesis that simultaneous knockdown of both genes would cause more severe 17 phenotypes. Investigating the genes together, rather than individually, could 18 provide a more complete understanding of how the genes in the WSCR contribute to 19 the phenotypes of WS. 20 Gtf2i and Gtf2ird1 are part of the General Transcription Factor 2i family of 21 genes. A third member, Gtf2ird2, is located in the WSCR that is variably deleted in 22 WS patients with larger deletions (13). This gene family arose from gene duplication 23 events, resulting in high sequence homology between the genes (14). The defining 3 bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 feature of this gene family is the presence of the helix-loop-helix I repeats, which are 2 involved in DNA and protein binding (15). Gtf2i’s roles include regulating 3 transcriptional activity in the nucleus. However, this multifunctional transcription 4 factor also exists in the cytoplasm where it conveys messages from extracellular 5 stimuli and regulates calcium entry into the cell (16,17). So far, Gtf2ird1 has only 6 been described in the nucleus of cells and is thought to regulate transcription and 7 associate with chromatin modifiers (18). The DNA binding of these two 8 transcription factors (TFs) has only been studied in ES cells and embryonic 9 craniofacial tissue. They recognize similar and disparate genomic loci, suggesting 10 the proteins interact to regulate specific regions of the genome (19,20). However, 11 binding of these TFs has not been studied in the developing brain, which could 12 provide more relevant insight on how the General Transcription Factor 2i family 13 contributes to cognitive and behavioral phenotypes. 14 We performed ChIP-seq on GTF2I and GTF2IRD1 in the developing mouse 15 brain to define where these TFs bind and then tested the downstream consequences 16 of disrupting this binding. We used the CRISPR/Cas9 system to make a mouse model 17 with a mutation in Gtf2ird1 alone and a mouse model with mutations in both Gtf2i 18 and Gtf2ird1 to test how adding a Gtf2i mutation modifies the effects of Gtf2ird1 19 mutation. We showed the mutation in Gtf2ird1 resulted in the production of an N- 20 truncated protein that disrupts the binding of GTF2IRD1 at the Gtf2ird1 promoter 21 and deregulates the transcription of Gtf2ird1, moderately decreasing protein levels 22 so homozygous mutants approximate levels expected from hemizygosity of the 23 WSCR. While there are mild consequences of the mutation on genome-wide 4 bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 transcription, the mutant mouse exhibited clear balance, marble burying, and 2 conditioned fear differences. Comparing the single gene mutant to the double 3 mutant did not reveal more severe transcriptional changes and behavioral 4 phenotypes, however adding Gtf2i on top of a background of two Gtf2ird1 mutations 5 resulted in abnormal pre-pulse inhibition and cued fear conditioning. This suggests 6 Gtf2ird1 drives the majority of the phenotypes observed in current studies, and total 7 protein level, N-terminal truncation, or both have functional consequences on DNA- 8 binding and behavior. 9 10 Results 11 12 Gtf2i and Gtf2ird1 bind at active promoters and conserved sites 13 14 The paralogous transcription factors, GTF2I and GTF2IRD1, have been 15 implicated in the behavioral phenotypes seen in humans with WS as well as mouse 16 models (4,8,11,12,21,22). However, the underlying mechanisms by which the 17 General Transcription Factor 2i family acts are not well understood. One approach 18 to begin to identify how these TFs can regulate phenotypes is by identifying where 19 they bind in the genome. This has been done in ES cells and embryonic facial tissue 20 and revealed that both of these transcription factors bind to genes involved in 21 craniofacial development (19). However, these are not relevant tissues when 22 considering phenotypes related to brain development and subsequent behavior. To 23 address this, we performed ChIP-seq for GTF2IRD1 and GTF2I in the developing 5 bioRxiv preprint doi: https://doi.org/10.1101/854851; this version posted December 3, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 brain at embryonic day 13.5 (E13.5), a time point when both of these proteins are 2 highly expressed (23). 3 We identified 1,410 peaks that were enriched in the GTF2IRD1 IP samples 4 compared to the input (Supplemental Table 1). The GTF2IRD1-bound regions 5 were strikingly enriched in the promoters of genes and along the gene body, more 6 so than would be expected by randomly sampling the genome (Figure 1A) (χ2 = 7 1537.8, d.f. =7, p < 2.2x10-16). The bound peaks were found mostly in H3K4me3 8 bound regions (OR=779.5, p<2.2x10-16 Fisher’s exact test (FET)), suggesting they are 9 in active sites in the genome.
Recommended publications
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Program Nr: 1 from the 2004 ASHG Annual Meeting Mutations in A
    Program Nr: 1 from the 2004 ASHG Annual Meeting Mutations in a novel member of the chromodomain gene family cause CHARGE syndrome. L.E.L.M. Vissers1, C.M.A. van Ravenswaaij1, R. Admiraal2, J.A. Hurst3, B.B.A. de Vries1, I.M. Janssen1, W.A. van der Vliet1, E.H.L.P.G. Huys1, P.J. de Jong4, B.C.J. Hamel1, E.F.P.M. Schoenmakers1, H.G. Brunner1, A. Geurts van Kessel1, J.A. Veltman1. 1) Dept Human Genetics, UMC Nijmegen, Nijmegen, Netherlands; 2) Dept Otorhinolaryngology, UMC Nijmegen, Nijmegen, Netherlands; 3) Dept Clinical Genetics, The Churchill Hospital, Oxford, United Kingdom; 4) Children's Hospital Oakland Research Institute, BACPAC Resources, Oakland, CA. CHARGE association denotes the non-random occurrence of ocular coloboma, heart defects, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies and deafness (OMIM #214800). Almost all patients with CHARGE association are sporadic and its cause was unknown. We and others hypothesized that CHARGE association is due to a genomic microdeletion or to a mutation in a gene affecting early embryonic development. In this study array- based comparative genomic hybridization (array CGH) was used to screen patients with CHARGE association for submicroscopic DNA copy number alterations. De novo overlapping microdeletions in 8q12 were identified in two patients on a genome-wide 1 Mb resolution BAC array. A 2.3 Mb region of deletion overlap was defined using a tiling resolution chromosome 8 microarray. Sequence analysis of genes residing within this critical region revealed mutations in the CHD7 gene in 10 of the 17 CHARGE patients without microdeletions, including 7 heterozygous stop-codon mutations.
    [Show full text]
  • Gene Expression Is Related to Parental Origin and Regional Coordinate Control
    Journal of Human Genetics (2009) 54, 193–198 & 2009 The Japan Society of Human Genetics All rights reserved 1434-5161/09 $32.00 www.nature.com/jhg ORIGINAL ARTICLE William’s syndrome: gene expression is related to parental origin and regional coordinate control Jeremy C Collette1, Xiao-Ning Chen1, Debra L Mills2, Albert M Galaburda3, Allan L Reiss4, Ursula Bellugi5 and Julie R Korenberg1,6 William’s syndrome (WS) features a spectrum of neurocognitive and behavioral abnormalities due to a rare 1.5 MB deletion that includes about 24–28 genes on chromosome band 7q11.23. Study of the expression of these genes from the single normal copy provides an opportunity to elucidate the genetic and epigenetic controls on these genes as well as their roles in both WS and normal brain development and function. We used quantitative RT-PCR to determine the transcriptional level of 14 WS gene markers in a cohort of 77 persons with WS and 48 normal controls. Results reported here: (1) show that the expression of the genes deleted in WS is decreased in some but not all cases, (2) demonstrate that the parental origin of the deletion contributes to the level of expression of GTF2I independently of age and gender and (3) indicate that the correlation of expression between GTF2I and some other genes in the WS region differs in WS subjects and normal controls, which in turn points toward a regulatory role for this gene. Interspecies comparisons suggest GTF2I may play a key role in normal brain development. Journal of Human Genetics (2009) 54, 193–198; doi:10.1038/jhg.2009.5; published online 13 March 2009 Keywords: William’s syndrome; gene expression; RT-PCR; parental origin; GTF2I INTRODUCTION As an approach toward understanding the role of the deleted genes William’s syndrome (WS) is a neurogenetic disorder affecting human in WS, we have characterized WS subjects according to genetic, social/ development and adult cognition.
    [Show full text]
  • Primary Driver Mutations in GTF2I Specific to the Development Of
    cancers Article Primary Driver Mutations in GTF2I Specific to the Development of Thymomas Rumi Higuchi 1, Taichiro Goto 1,* , Yosuke Hirotsu 2 , Yujiro Yokoyama 1, Takahiro Nakagomi 1, Sotaro Otake 1, Kenji Amemiya 2,3, Toshio Oyama 3, Hitoshi Mochizuki 2 and Masao Omata 2,4 1 Lung Cancer and Respiratory Disease Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] (R.H.); [email protected] (Y.Y.); [email protected] (T.N.); [email protected] (S.O.) 2 Genome Analysis Center, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] (Y.H.); [email protected] (K.A.); [email protected] (H.M.); [email protected] (M.O.) 3 Department of Pathology, Yamanashi Central Hospital, Yamanashi 400-8506, Japan; [email protected] 4 Department of Gastroenterology, The University of Tokyo Hospital, Tokyo 113-8655, Japan * Correspondence: [email protected]; Tel.: +81-55-253-7111 Received: 16 June 2020; Accepted: 22 July 2020; Published: 24 July 2020 Abstract: Thymomas are rare mediastinal tumors that are difficult to treat and pose a major public health concern. Identifying mutations in target genes is vital for the development of novel therapeutic strategies. Type A thymomas possess a missense mutation in GTF2I (chromosome 7 c.74146970T>A) with high frequency. However, the molecular pathways underlying the tumorigenesis of other thymomas remain to be elucidated. We aimed to detect this missense mutation in GTF2I in other thymoma subtypes (types B). This study involved 22 patients who underwent surgery for thymomas between January 2014 and August 2019.
    [Show full text]
  • Whole Genome Comparative Genomic Hybridization of Ewing Sarcoma Indicates Cytoskeleton, Migration and Protein Trafficking †
    Proceedings Whole Genome Comparative Genomic Hybridization of Ewing Sarcoma Indicates Cytoskeleton, Migration and Protein Trafficking † Burçin Baran 1, Safiye Aktaş 1,*, Hülya Tosun 1,2, Gülden Diniz 1,2, Yasemin Çakır 1,2, Tekincan Çağrı Aktaş 1, Zekiye Altun 1 and Nur Olgun 1 1 Institute of Oncology, Dokuz Eylul University, Izmir 35340, Turkey; [email protected] (B.B.); [email protected] (H.T.); [email protected] (G.D.); [email protected] (Y.Ç.); [email protected] (T.Ç.A.); [email protected] (Z.A.); [email protected] (N.O.) 2 Dr.Behcet Uz Children’s Research Hospital, Izmir 35210, Turkey * Correspondence: [email protected] † Presented at the 2nd International Cell Death Research Congress, Izmir, Turkey, 1–4 November 2018. Published: 5 December 2018 Abstract: Ewing sarcoma is a bone and soft tissue tumor either neuroectodermal or mesenchymal originated and affecting children and adolescents. In the present study, we aimed to find out prognostic and predictive biomarkers for Ewing sarcoma. Hence, we examined the copy number alterations (and related possible genes) among ten Ewing sarcoma patient samples and possible associations with the clinical outcome. DNA extraction from formalin fixed paraffin embedded archive tissues was performed. Whole genome Comparative Genomic Hybridization (CGH) was performed by NimbleGen and recorded as single Panel Rainbow through chromosomes 1–22, X and Y. Data was interpreted by SignalMap software and genetic regions matching the deletion or amplification loci were recorded. The mean age of the patients was 8.6 years. Three of the cases were male, while seven were female. According to CGH analysis, the most common DNA copy number alterations were found in SLIT-ROBO Rho GTPase activating protein (srGAP2), RANBP2 like GRIP domain (RGPD5), nephrocystin 1 (NPHP1), GTF2I repeat domain containing 2 (GTF2IRD2), pyridoxal dependent decarboxylase domain containing 1 (PXDC1), which were found down- regulated among 7 of 10 patients.
    [Show full text]
  • The Nuclear Localization Pattern and Interaction Partners of GTF2IRD1 Demonstrate a Role in Chromatin Regulation
    Hum Genet DOI 10.1007/s00439-015-1591-0 ORIGINAL INVESTIGATION The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation Paulina Carmona‑Mora1 · Jocelyn Widagdo2 · Florence Tomasetig1 · Cesar P. Canales1 · Yeojoon Cha1 · Wei Lee1 · Abdullah Alshawaf3 · Mirella Dottori3 · Renee M. Whan4 · Edna C. Hardeman1 · Stephen J. Palmer1 Received: 11 February 2015 / Accepted: 4 August 2015 © Springer-Verlag Berlin Heidelberg 2015 Abstract GTF2IRD1 is one of the three members of the mostly involved in chromatin modification and transcrip- GTF2I gene family, clustered on chromosome 7 within a tional regulation, whilst others indicate an unexpected role 1.8 Mb region that is prone to duplications and deletions in connection with the primary cilium. Mapping of the sites in humans. Hemizygous deletions cause Williams–Beuren of protein interaction also indicates key features regarding syndrome (WBS) and duplications cause WBS duplica- the evolution of the GTF2IRD1 protein. These data provide tion syndrome. These copy number variations disturb a a visual and molecular basis for GTF2IRD1 nuclear func- variety of developmental systems and neurological func- tion that will lead to an understanding of its role in brain, tions. Human mapping data and analyses of knockout mice behaviour and human disease. show that GTF2IRD1 and GTF2I underpin the craniofacial abnormalities, mental retardation, visuospatial deficits and Abbreviations hypersociability of WBS. However, the cellular role of the hESC Human embryonic stem cells GTF2IRD1 protein is poorly understood due to its very PLA Proximity ligation assay low abundance and a paucity of reagents. Here, for the first STED Stimulated emission depletion time, we show that endogenous GTF2IRD1 has a punctate WBS Williams–Beuren syndrome pattern in the nuclei of cultured human cell lines and neu- Y2H Yeast two-hybrid rons.
    [Show full text]
  • The Tumor Suppressor Notch Inhibits Head and Neck Squamous Cell
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2015 THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) Shhyam Moorthy Shhyam Moorthy Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Biochemistry, Biophysics, and Structural Biology Commons, Cancer Biology Commons, Cell Biology Commons, and the Medicine and Health Sciences Commons Recommended Citation Moorthy, Shhyam and Moorthy, Shhyam, "THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN)" (2015). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 638. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/638 This Dissertation (PhD) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. THE TUMOR SUPPRESSOR NOTCH INHIBITS HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) TUMOR GROWTH AND PROGRESSION BY MODULATING PROTO-ONCOGENES AXL AND CTNNAL1 (α-CATULIN) by Shhyam Moorthy, B.S.
    [Show full text]
  • GTF2IRD1 Rabbit Polyclonal Antibody – AP06760PU-N | Origene
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for AP06760PU-N GTF2IRD1 Rabbit Polyclonal Antibody Product data: Product Type: Primary Antibodies Applications: WB Recommended Dilution: Western blot: 1/500-1/1000. Reactivity: Human, Mouse, Rat Host: Rabbit Clonality: Polyclonal Immunogen: Synthetic peptide, corresponding to amino acids 63-112 of Human WBSCR11. Specificity: This antibody detects endogenous levels of WBSCR11 protein. (region surrounding Lys94) Formulation: Phosphate buffered saline (PBS), pH~7.2 State: Aff - Purified State: Liquid purified Ig fraction (> 95% pure by SDS-PAGE) Preservative: 0.05% Sodium Azide Concentration: 1.0 mg/ml Purification: Affinity Chromatography using epitope-specific immunogen Conjugation: Unconjugated Storage: Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Stability: Shelf life: one year from despatch. Predicted Protein Size: ~106 kDa Database Link: Entrez Gene 9569 Human Q9UHL9 This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 GTF2IRD1 Rabbit Polyclonal Antibody – AP06760PU-N Background: Williams-Beuren syndrome (WBS) is a developmental disorder caused by the hemizygous microdeletion on chromosome 7q11.23. WBS is an autosomal dominant genetic condition that is characterized by physical, cognitive and behavioral traits. The physical traits associated with WBS include facial dysmorphology, vascular stenoses, growth deficiencies, dental anomalies and neurologic and musculoskeletal abnormalities.
    [Show full text]
  • Curcumin Alters Gene Expression-Associated DNA Damage, Cell Cycle, Cell Survival and Cell Migration and Invasion in NCI-H460 Human Lung Cancer Cells in Vitro
    ONCOLOGY REPORTS 34: 1853-1874, 2015 Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro I-TSANG CHIANG1,2, WEI-SHU WANG3, HSIN-CHUNG LIU4, SU-TSO YANG5, NOU-YING TANG6 and JING-GUNG CHUNG4,7 1Department of Radiation Oncology, National Yang‑Ming University Hospital, Yilan 260; 2Department of Radiological Technology, Central Taiwan University of Science and Technology, Taichung 40601; 3Department of Internal Medicine, National Yang‑Ming University Hospital, Yilan 260; 4Department of Biological Science and Technology, China Medical University, Taichung 404; 5Department of Radiology, China Medical University Hospital, Taichung 404; 6Graduate Institute of Chinese Medicine, China Medical University, Taichung 404; 7Department of Biotechnology, Asia University, Taichung 404, Taiwan, R.O.C. Received March 31, 2015; Accepted June 26, 2015 DOI: 10.3892/or.2015.4159 Abstract. Lung cancer is the most common cause of cancer CARD6, ID1 and ID2 genes, associated with cell survival and mortality and new cases are on the increase worldwide. the BRMS1L, associated with cell migration and invasion. However, the treatment of lung cancer remains unsatisfactory. Additionally, 59 downregulated genes exhibited a >4-fold Curcumin has been shown to induce cell death in many human change, including the DDIT3 gene, associated with DNA cancer cells, including human lung cancer cells. However, the damage; while 97 genes had a >3- to 4-fold change including the effects of curcumin on genetic mechanisms associated with DDIT4 gene, associated with DNA damage; the CCPG1 gene, these actions remain unclear. Curcumin (2 µM) was added associated with cell cycle and 321 genes with a >2- to 3-fold to NCI-H460 human lung cancer cells and the cells were including the GADD45A and CGREF1 genes, associated with incubated for 24 h.
    [Show full text]
  • Supplementary Figure Legends
    1 Supplementary Figure legends 2 Supplementary Figure 1. 3 Experimental workflow. 4 5 Supplementary Figure 2. 6 IRF9 binding to promoters. 7 a) Verification of mIRF9 antibody by site-directed ChIP. IFNβ-stimulated binding of IRF9 to 8 the ISRE sequences of Mx2 was analyzed using BMDMs of WT and Irf9−/− (IRF9-/-) mice. 9 Cells were treated with 250 IU/ml of IFNβ for 1.5h. Data represent mean and SEM values of 10 three independent experiments. P-values were calculated using the paired ratio t-test (*P ≤ 11 0.05; **P ≤ 0.01, ***P ≤ 0.001). 12 b) Browser tracks showing complexes assigned as STAT-IRF9 in IFNγ treated wild type 13 BMDMs. Input, STAT2, IRF9 (scale 0-200). STAT1 (scale 0-150). 14 15 Supplementary Figure 3. 16 Experimental system for BioID. 17 a) Kinetics of STAT1, STAT2 and IRF9 synthesis in Raw 264.7 macrophages and wild type 18 BMDMs treated with 250 IU/ml as indicated. Whole-cell extracts were tested in western blot 19 for STAT1 phosphorylation at Y701 and of STAT2 at Y689 as well as total STAT1, STAT2, 20 IRF9 and GAPDH levels. The blots are representative of three independent experiments. b) 21 Irf9-/- mouse embryonic fibroblasts (MEFs) were transiently transfected with the indicated 22 expression vectors, including constitutively active IRF7-M15. One day after transfection, 23 RNA was isolated and Mx2 expression determined by qPCR. c) Myc-BirA*-IRF9 transgenic 24 Raw 264.7 were treated with increasing amounts of doxycycline (dox) (0,2µg/ml, 0,4µg/ml, 25 0,6µg/ml, 0,8µg/ml, 1mg/ml) and 50µM biotin.
    [Show full text]
  • Characterization of Williams-Beuren Syndrome Mouse Models: Linking Genes with Cognition and Behaviour
    Characterization of Williams-Beuren Syndrome Mouse Models: Linking Genes with Cognition and Behaviour by Emily Lam A thesis submitted in conformity with the requirements for the degree of Master of Science Institute of Medical Science University of Toronto © Copyright by Emily Lam (2012) Characterization of Williams-Beuren Syndrome Mouse Models: Linking Genes with Cognition and Behaviour Emily Lam Master of Science Institute of Medical Science University of Toronto 2012 Abstract Deletion (Williams-Beuren syndrome (WBS)) and duplication (Dup7q11.23) of a common interval spanning 26 genes on chromosome 7q11.23 cause disorders with a spectrum of clinical, cognitive and behavioural symptoms. Studies of individuals with atypical deletions have implicated two genes, GTF2IRD1 and GTF2I. Here I describe the behavioural characterization of mice hemizygous for Gtf2i, or Gtf2ird1 and Gtf2i together, as well as mice with additional Gtf2i copies. Dosage changes in Gtf2i were associated with working memory impairment and separation anxiety, and possibly with general anxiety and repetitive behaviours. A potential cause of these phenotypes was found in brain tissue, where subcellular localization of the calcium channel TRPC3, which is regulated by GTF2I, was found to be altered. Collectively, these results provide a better understanding of the contributions of GTF2I to the cognitive and behavioural profile of WBS and Dup7q11.23 and identify a potential biological mechanism that may underlie some of the symptoms. ii Acknowledgements I would like to extend my deepest gratitude to my supervisor, Dr. Lucy Osborne, for her continuous guidance and support throughout the duration of my graduate studies. Lucy’s bright laughter in the lab is always an encouraging sign that, despite the bad days, there are always good times to look forward to in grad school! I would also like to thank the members of my program advisory committee, Dr.
    [Show full text]
  • Effects of Altered Gtf2i and Gtf2ird1 Expression on the Growth of Neural Progenitors and Organization of the Mouse Cortex
    Effects of altered Gtf2i and Gtf2ird1 expression on the growth of neural progenitors and organization of the mouse cortex by Hyemin Amy Oh A thesis submitted in conformity with the requirements For the degree of Master of Science Institute of Medical Science University of Toronto © Copyright by Hyemin Amy Oh (2013) Effects of altered Gtf2i and Gtf2ird1 expression on the growth of neural progenitors and organizations of the mouse cortex Hyemin Amy Oh Master of Science Institute of Medical Science University of Toronto 2013 Abstract Williams-Beuren syndrome (WBS) and 7q11.23 Duplication Syndrome (Dup7) are rare neurodevelopmental disorders associated with a range of cognitive and behavioural symptoms, caused by the deletion and duplication, respectively, of 26 genes on human chromosome 7q11.23. I have studied the effects of deletion or duplication of two candidate genes, GTF2I and GTF2IRD1, on neural stem cell growth and neurogenesis using cultured primary neuronal precursors from mouse models with gene copy number changes. I found that the number of neuronal precursors and committed neurons was directly related to the copy number of these genes in the mid-gestation embryonic cortex. I further found that in late-gestation embryos, cortical thickness was altered in a similar gene dose-dependent manner, in combination with layer-specific changes in neuronal density. I hypothesize that some of the neurological features of WS and Dup7 stem from these impairments in early cortical development ii Acknowledgement I would like to take this opportunity to thank Dr. Lucy Osborne for her continuous support and guidance. She is not just a supervisor but also a mentor as well as a motherly figure for me.
    [Show full text]